| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $65.0K | $135.0K | $550.0K |
| YoY Revenue Growth % | -51.9% | -75.5% | — |
| Gross Profit | -$256.0K | $12.0K | — |
| Gross Margin % | -50.0% | 8.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$21.1M | -$19.3M | -$20.7M |
| Operating Margin % | -80.0% | -80.0% | -80.0% |
| Net Income (GAAP) | -$20.2M | -$18.4M | -$19.8M |
| EBITDA (Normalized) | -$21.1M | -$19.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$14.9M | -$13.2M | -$14.6M |
| Capital Expenditures (CapEx) | $49.0K | $14.0K | — |
| Free Cash Flow (FCF) | -$14.9M | -$13.3M | -$14.6M |
| FCF Margin % | -80.0% | -80.0% | -80.0% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $19.2M | $25.8M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $18.4M | $25.1M | — |